Series A
$15m
Clinical Genomics Announces Closing of $15 Million Series A Financing Round
Diagnostics company Clinical Genomics closed a $15m Series A led by Sydney VC OneVentures to commercialise its blood test for monitoring bowel cancer recurrence; OneVentures partner Dr Paul Kelly joins its board.